BridgeMD
New treatment option for Parkinson's Disease (PD)
Official title Moving Yourself in Space and Time: MYSTIC
ClinicalTrials.gov ID: NCT07697664
What this study is testing
- What it's testing
- This study is being done to answer the question: Do people with Parkinson's benefit from a new stepping therapy, and how do people with Parkinson's best learn new steps and rhythms set to music? Researchers will also compare individuals with Parkinson's Disease with people with Mild Cognitive Impairment, and with people with neither of these conditions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 79. Healthy volunteers may be eligible.
You may be able to join if
- for Young adults and adults with normal cognition (NC):
- 18 to 35 Years old
- Montreal Cognitive Assessment (MoCA) score of 26 to 30 for Older Adults:
- 50 to 79 with or without MCI
- 50 to 79 years old with Parkinson's disease (PD), who do NOT have impaired decision-making capacity
You likely can't join if
- for all groups:
- Acute medical illness requiring hospitalization;
- Uncontrolled congestive heart failure;
- History of stroke in the past three years;
- Inability to perform study procedures;
- Medical or physical conditions that would preclude participation (e.g., severe arthritis or mobility problems, uncontrolled hypertension or diabetes...
See the full eligibility criteria
- for Young adults and adults with normal cognition (NC):
- 18 to 35 Years old
- Montreal Cognitive Assessment (MoCA) score of 26 to 30 for Older Adults:
- 50 to 79 with or without MCI
- 50 to 79 years old with Parkinson's disease (PD), who do NOT have impaired decision-making capacity
- Participants who achieve less than 150 minutes moderate or 75 minutes vigorous aerobic activity per week (as per the US Department of Health and Human Services (HHS)),
- for all groups:
- Acute medical illness requiring hospitalization;
- Uncontrolled congestive heart failure;
- History of stroke in the past three years;
- Inability to perform study procedures;
- Medical or physical conditions that would preclude participation (e.g., severe arthritis or mobility problems, uncontrolled hypertension or diabetes, renal failure, history of angina with activity);
- On medications that could adversely affect cognition, e.g., antipsychotics, opioids, stimulants, chemotherapy, and neurologic prescriptions to treat Multiple Sclerosis. When applicable, enrollment will be delayed until...
- Psychotic disorders
- Confounding neurologic conditions [e.g., active central nervous system (CNS) opportunistic infections, seizure disorders, head injury with loss of consciousness \>30 minutes, intracranial neoplasms, stroke with...
- Substance Use Disorder, Major Depressive Disorder, and Generalized Anxiety Disorder within six months of evaluation.
- Inability to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 79 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.